Mucosal melanoma of hard palate
DOI:
https://doi.org/10.4322/acr.2024.522Keywords:
Melanoma, Malignant, Palate, Hard, Cancer, Mucous MembraneAbstract
Melanoma arising in the hard palate is an exceedingly rare entity, comprising a minute fraction of all melanoma cases. The absence of specific clinical signs often leads to delayed diagnosis and subsequent challenges in treatment planning. We discussed the existing literature to elucidate the epidemiology, risk factors, and molecular pathways associated with melanoma of the hard palate. Additionally, we discuss the importance of a multidisciplinary approach involving dermatologists, otolaryngologists, oncologists, and pathologists in diagnosing and managing this condition. A 62-year-old male patient presented with a pigmented lesion on the hard palate mucosa, which was initially asymptomatic but gradually increased in size. Biopsy revealed melanoma, confirmed through immunohistochemical staining. Staging investigations indicated a metastatic disease. Surgery followed by adjuvant therapy was planned; however, he was lost for the follow-up. Melanoma originating from the hard palate mucosa is exceedingly rare, posing diagnostic and therapeutic challenges. Early detection, accurate diagnosis, and prompt multidisciplinary management are crucial for optimal outcomes. This case underscores the importance of comprehensive evaluation and tailored treatment strategies in patients with uncommon mucosal melanomas.Downloads
References
Correia-Neto IJ, Correa MB, Araújo ALD, et al. A primary oral mucosal melanoma of the hard palate with no recurrence: report of a 10 years follow-up. Spec Care Dentist. 2024;44(3):751-5. http://doi.org/10.1111/scd.12928. PMid:37814400.
Oranges CM, Sisti G, Nasioudis D, et al. Hard palate melanoma: a population-based analysis of epidemiology and survival outcomes. Anticancer Res. 2018;38(10):5811-7. http://doi.org/10.21873/anticanres.12921. PMid:30275204.
Ashok S, Damera S, Ganesh S, Karri R. Oral malignant melanoma. J Oral Maxillofac Pathol. 2020;24(4, Suppl 1):S82-5. http://doi.org/10.4103/jomfp.JOMFP_5_19. PMid:32189911.
Sen S, Sen S, Kumari MG, Khan S, Singh S. Oral malignant melanoma: a case report. Prague Med Rep. 2021;122(3):222-7. http://doi.org/10.14712/23362936.2021.20. PMid:34606435.
Kuk D, Shoushtari AN, Barker CA, et al. Prognosis of mucosal, uveal, acral, nonacral cutaneous, and unknown primary melanoma from the time of first metastasis. Oncologist. 2016;21(7):848-54. http://doi.org/10.1634/theoncologist.2015-0522. PMid:27286787.
Barker BF, Carpenter WM, Daniels TE, et al. Oral mucosal melanomas: the WESTOP Banff Workshop Proceedings. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 1997;83(6):672-9. http://doi.org/10.1016/S1079-2104(97)90318-8. PMid:9195622.
Song H, Wang L, Lyu J, Wu Y, Guo W, Ren G. Loss of nuclear BAP1 expression is associated with poor prognosis in oral mucosal melanoma. Oncotarget. 2017;8(17):29080-90. http://doi.org/10.18632/oncotarget.16175. PMid:28404968.
Prasad ML, Patel SG, Huvos AG, Shah JP, Busam KJ. Primary mucosal melanoma of the head and neck: a proposal for microstaging localized, Stage I (lymph node-negative) tumors. Cancer. 2004;100(8):1657-64. http://doi.org/10.1002/cncr.20201. PMid:15073854.
Patel SG, Prasad ML, Escrig M, et al. Primary mucosal malignant melanoma of the head and neck. Head Neck. 2002;24(3):247-57. http://doi.org/10.1002/hed.10019. PMid:11891956.
Naganawa K, Koto M, Takagi R, et al. Long-term outcomes after carbon-ion radiotherapy for oral mucosal malignant melanoma. J Radiat Res (Tokyo). 2017;58(4):517-22. http://doi.org/10.1093/jrr/rrw117. PMid:28028129.
Andrade BA, León JE, Carlos R, et al. Expression of fatty acid synthase (FASN) in oral nevi and melanoma. Oral Dis. 2011;17(8):808-12. http://doi.org/10.1111/j.1601-0825.2011.01841.x. PMid:21819495.
Downloads
Published
Issue
Section
License
Copyright (c) 2024 Zahed Ali Qamer, Monika Maharjan, Kranthi Kumar Jandrasupalli, Bommisetty Lokesh, Amit Tyagi, Ravi Hari Phulware
This work is licensed under a Creative Commons Attribution 4.0 International License.
Copyright
Authors of articles published by Autopsy and Case Report retain the copyright of their work without restrictions, licensing it under the Creative Commons Attribution License - CC-BY, which allows articles to be re-used and re-distributed without restriction, as long as the original work is correctly cited.